Literature DB >> 10407780

Disorders of mitochondrial fatty acyl-CoA beta-oxidation.

R J Wanders1, P Vreken, M E den Boer, F A Wijburg, A H van Gennip, L IJlst.   

Abstract

In recent years tremendous progress has been made with respect to the enzymology of the mitochondrial fatty acid beta-oxidation machinery and defects therein. Firstly, a number of new mitochondrial beta-oxidation enzymes have been identified, including very-long-chain acyl-CoA dehydrogenase (VLCAD) and mitochondrial trifunctional protein (MTP). Secondly, the introduction of tandem MS for the analysis of plasma acylcarnitines has greatly facilitated the identification of patients with a defect in fatty acid oxidation (FAO). These two developments explain why the number of defined FAO disorders has increased dramatically, making FAO disorders the most rapidly growing group of inborn errors of metabolism. In this review we describe the current state of knowledge of the enzymes involved in the mitochondrial oxidation of straight-chain, branched-chain and (poly)unsaturated fatty acyl-CoAs as well as disorders of fatty acid oxidation. The laboratory diagnosis of these disorders is described, with particular emphasis on the methods used to identify the underlying enzyme defect and the molecular mutations. In addition, a simple flowchart is presented as a guide to the identification of mitochondrial FAO-disorders. Finally, treatment strategies are discussed briefly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407780     DOI: 10.1023/a:1005504223140

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  176 in total

1.  Short-chain acyl-CoA dehydrogenase deficiency in a 16-year-old girl with severe muscle wasting and scoliosis.

Authors:  K E Baerlocher; B Steinmann; A Aguzzi; S Krähenbühl; C R Roe; C Vianey-Saban
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

2.  Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase.

Authors:  R J Wanders; M Duran; L Ijlst; J P de Jager; A H van Gennip; C Jakobs; L Dorland; F J van Sprang
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

3.  Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene.

Authors:  L IJlst; J P Ruiter; J M Hoovers; M E Jakobs; R J Wanders
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  Ketonuria and medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  J S Patel; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  The existence of two mitochondrial isoforms of 2,4-dienoyl-CoA reductase in the rat.

Authors:  E H Hakkola; J K Hiltunen
Journal:  Eur J Biochem       Date:  1993-07-01

6.  Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients.

Authors:  C Vianey-Saban; P Divry; M Brivet; M Nada; M T Zabot; M Mathieu; C Roe
Journal:  Clin Chim Acta       Date:  1998-01-12       Impact factor: 3.786

7.  Purification and characterization of an alpha-methylacyl-CoA racemase from human liver.

Authors:  W Schmitz; C Albers; R Fingerhut; E Conzelmann
Journal:  Eur J Biochem       Date:  1995-08-01

8.  A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.

Authors:  T Aoyama; Y Uchida; R I Kelley; M Marble; K Hofman; J H Tonsgard; W J Rhead; T Hashimoto
Journal:  Biochem Biophys Res Commun       Date:  1993-03-31       Impact factor: 3.575

9.  Combined enzyme defect of mitochondrial fatty acid oxidation.

Authors:  S Jackson; R S Kler; K Bartlett; H Briggs; L A Bindoff; M Pourfarzam; D Gardner-Medwin; D M Turnbull
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities.

Authors:  F Demaugre; J P Bonnefont; G Mitchell; N Nguyen-Hoang; A Pelet; M Rimoldi; S Di Donato; J M Saudubray
Journal:  Pediatr Res       Date:  1988-09       Impact factor: 3.756

View more
  71 in total

Review 1.  Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.

Authors:  Ute Spiekerkoetter; Philip A Wood
Journal:  J Inherit Metab Dis       Date:  2010-06-08       Impact factor: 4.982

2.  VLCAD enzyme activity determinations in newborns identified by screening: a valuable tool for risk assessment.

Authors:  Lars Hoffmann; Ulrike Haussmann; Martina Mueller; Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2011-09-20       Impact factor: 4.982

3.  Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency.

Authors:  H H Huidekoper; J Schneider; T Westphal; F M Vaz; M Duran; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2006-08-02       Impact factor: 4.982

Review 4.  Acute fatty liver of pregnancy.

Authors:  H Ko; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

5.  Immunohistochemical localization of mitochondrial fatty acid β-oxidation enzymes in Müller cells of the retina.

Authors:  Kimie Atsuzawa; Ayami Nakazawa; Kenmei Mizutani; Motoaki Fukasawa; Naoki Yamamoto; Takashi Hashimoto; Nobuteru Usuda
Journal:  Histochem Cell Biol       Date:  2010-11-03       Impact factor: 4.304

6.  Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy.

Authors:  S Gobin-Limballe; F Djouadi; F Aubey; S Olpin; B S Andresen; S Yamaguchi; H Mandel; T Fukao; J P N Ruiter; R J A Wanders; R McAndrew; J J Kim; J Bastin
Journal:  Am J Hum Genet       Date:  2007-10-29       Impact factor: 11.025

Review 7.  Fatty acid metabolism by the osteoblast.

Authors:  Priyanka Kushwaha; Michael J Wolfgang; Ryan C Riddle
Journal:  Bone       Date:  2017-08-31       Impact factor: 4.398

8.  Clinical features and mutations in seven Chinese patients with very long chain acyl-CoA dehydrogenase deficiency.

Authors:  Rui-Nan Zhang; Yi-Fan Li; Wen-Juan Qiu; Jun Ye; Lian-Shu Han; Hui-Wen Zhang; Na Lin; Xue-Fan Gu
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

9.  Development of a Tandem Mass Spectrometry Method for Rapid Measurement of Medium- and Very-Long-Chain Acyl-CoA Dehydrogenase Activity in Fibroblasts.

Authors:  Damien Bouvier; Christine Vianey-Saban; Séverine Ruet; Cécile Acquaviva
Journal:  JIMD Rep       Date:  2016-12-10

10.  Corresponding increase in long-chain acyl-CoA and acylcarnitine after exercise in muscle from VLCAD mice.

Authors:  Frank ter Veld; Sonja Primassin; Lars Hoffmann; Ertan Mayatepek; Ute Spiekerkoetter
Journal:  J Lipid Res       Date:  2008-10-31       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.